MiniMed rises as FDA clears smartphone‑controlled insulin pump

Minimed

18/03/2026 13:43

** Shares of medical device maker MiniMed MMED.O rise up 1.25% to $17.04

** Co says FDA clears MiniMed Flex insulin pump, its first device controlled via a smartphone app

** Flex is about half the size of the MiniMed 780G, has no screen and adjusts insulin delivery automatically using an adaptive algorithm, Co says

** Device works with MiniMed’s latest sensors, including products from Abbott, and holds 300 units of insulin, co says

** Cleared for people aged 7 and older with type 1 diabetes and adults with insulin‑requiring type 2 diabetes, co says

** Says rollout to start with select customers this spring, with a broader launch planned for summer

** Shares are down ~15% from their March IPO price of $20

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))